255 related articles for article (PubMed ID: 37350370)
1. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
Zidan A; Awaisu A
Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
[TBL] [Abstract][Full Text] [Related]
2. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
[TBL] [Abstract][Full Text] [Related]
3. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
4. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
5. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
6. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
7. [Deprescribing of inappropriate medication in primary care].
Høj K; Mygind A; Livbjerg S; Bro F
Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267949
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
9. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
10. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium.
Carollo M; Boccardi V; Crisafulli S; Conti V; Gnerre P; Miozzo S; Omodeo Salè E; Pieraccini F; Zamboni M; Marengoni A; Onder G; Trifirò G;
Aging Clin Exp Res; 2024 Mar; 36(1):63. PubMed ID: 38459218
[TBL] [Abstract][Full Text] [Related]
11. Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review.
Aubert CE; Kerr EA; Maratt JK; Klamerus ML; Hofer TP
J Am Geriatr Soc; 2020 Oct; 68(10):2390-2398. PubMed ID: 32780416
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing in Older Adults With Cardiovascular Disease.
Krishnaswami A; Steinman MA; Goyal P; Zullo AR; Anderson TS; Birtcher KK; Goodlin SJ; Maurer MS; Alexander KP; Rich MW; Tjia J;
J Am Coll Cardiol; 2019 May; 73(20):2584-2595. PubMed ID: 31118153
[TBL] [Abstract][Full Text] [Related]
13. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy in elderly people.
Dovjak P
Wien Med Wochenschr; 2022 Apr; 172(5-6):109-113. PubMed ID: 35006518
[TBL] [Abstract][Full Text] [Related]
15. The Role of Patient Preferences in Deprescribing.
Holmes HM; Todd A
Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989
[TBL] [Abstract][Full Text] [Related]
16. Drug Prescribing: Polypharmacy and Deprescribing.
McQuade BM; Campbell A
FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
[TBL] [Abstract][Full Text] [Related]
17. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks.
McDonald EG; Lundby C; Thompson W; Boyd C; Farrell B; Gagnon C; Herbin J; Khuong N; Moriarty F; Pierson T; Scott S; Scott IA; Silvius J; Spinewine A; Steinman MA; Tannenbaum C; Trimble J; Turner JP; Reeve E
Expert Rev Clin Pharmacol; 2024; 17(5-6):433-440. PubMed ID: 38739460
[TBL] [Abstract][Full Text] [Related]
18. Rationalizing prescription via deprescribing in oncology practice.
Raju B; Chaudhary RK; L A; Babu A; Sandeep A; Mateti UV
J Oncol Pharm Pract; 2023 Dec; 29(8):2007-2013. PubMed ID: 37847585
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
Rochon PA; Petrovic M; Cherubini A; Onder G; O'Mahony D; Sternberg SA; Stall NM; Gurwitz JH
Lancet Healthy Longev; 2021 May; 2(5):e290-e300. PubMed ID: 36098136
[TBL] [Abstract][Full Text] [Related]
20. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
